Stephane Borentain
5PUBLICATIONS
2CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Oct 11, 2022
Commentary on Cochrane review: "Ketamine and other glutamate receptor modulators for depression in adults with unipolar major depressive disorder".Stephane Borentain, Pooja Desai, Dong-Jing Fu
|Jun 24, 2022
Montgomery-Åsberg Depression Rating Scale factors in treatment-resistant depression at onset of treatment: Derivation, replication, and change over time during treatment with esketamine.Stephane Borentain, Jagadish Gogate, David Williamson
|Jun 16, 2022
Use of Clinical Global Impressions-Severity (CGI-S) to Assess Response to Antidepressant Treatment in Patients with Treatment-Resistant Depression.Joachim Morrens, Maju Mathews, Vanina Popova
|Dec 09, 2021
Effect of Sleep Disturbance on Efficacy of Esketamine in Treatment-Resistant Depression: Findings from Randomized Controlled Trials.Stephane Borentain, David Williamson, Ibrahim Turkoz
|Jul 22, 2021
Effect of Concomitant Benzodiazepine Use on Efficacy and Safety of Esketamine Nasal Spray in Patients with Major Depressive Disorder and Acute Suicidal Ideation or Behavior: Pooled Randomized, Controlled Trials.Bettina Diekamp, Stephane Borentain, Dong-Jing Fu
Pageof 1
